紅星美凱龍(01528.HK)訂規管基金及類REITS計劃之第二期管理協議
紅星美凱龍(01528.HK)公佈,於2021年10月15日訂立若幹協議,以規管基金及類REITS計劃之第二期的管理。
公司的直接全資附屬公司上海紅星管理訂立委託經營管理合同,爲期八年,據此,公司應透過上海紅星管理向家居商場提供管理服務。於委託經營管理合同期限內,倘家居商場未能達到指定經營現金流量淨額目標,公司須補足任何差額;同時,倘家居商場超過該等目標並符合其他相關要求後,公司將收取超額部分的70%作爲冠名委管費。
另外,在渤海匯金於類REITS計劃之第二期的出售階段出售類REITS計劃之第二期任何該等標的資產情況下,公司將保留優先購買權以收購任一標的資產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.